PURPOSE: Preparation, in vitro and in vivo evaluation of indomethacin-loaded polymeric micelles based on amphiphilic polyphosphazene. METHODS: Amphiphilic polyphosphazenes (PNIPAAm/EAB-PPPs) with poly (N-isopropylacrylamide) (PNIPAAm) and ethyl 4-aminobenzoate (EAB) as side groups were synthesized through thermal ring-opening polymerization and subsequent substitution reactions. Indomethacin (IND) loaded polymeric micelles based on PNIPAAm/EAB-PPPs were prepared by dialysis procedure. In vitro IND release kinetics was investigated in 0.1 M PBS (pH 7.4), while in vivo pharmacokinetics was performed in Sprague-Dawley rats. In vivo pharmacodynamic study was carried out based on two animal models, i.e. carrageenan-induced acute paw edema and complete Freund's adjuvant (CFA) induced ankle arthritis model. RESULTS: Drug loading capacity of micelles based on this type of amphiphilic copolymers was mainly determined by copolymer composition and the chemical structure of drug. In addition to the compatibility between drug and micellar core, hydrogen bonding interaction between drug and hydrophilic corona may significantly influence drug loading as well. In vitro drug release in PBS suggested that there was no significant difference in release rate between micelles based on copolymers with various EAB content. Compared with the rats administered with free IND aqueous solution, IND concentration in rats' plasma showed a prolonged maintenance in experimental group treated with IND-loaded polymeric micelles. In vivo pharmacodynamic study indicated that sustained therapeutic efficacy could be achieved through topical injection of the aqueous solution of IND-loaded micelles. Local delivery of IND can avoid the severe gastrointestinal stimulation, which was frequently associated with oral administration as evidenced by ulceration evaluation. CONCLUSIONS: The promising results of current preliminary study suggest that this type of amphiphilic copolymers could be used as injectable drug carriers for hydrophobic drugs.
PURPOSE: Preparation, in vitro and in vivo evaluation of indomethacin-loaded polymeric micelles based on amphiphilic polyphosphazene. METHODS: Amphiphilic polyphosphazenes (PNIPAAm/EAB-PPPs) with poly (N-isopropylacrylamide) (PNIPAAm) and ethyl 4-aminobenzoate (EAB) as side groups were synthesized through thermal ring-opening polymerization and subsequent substitution reactions. Indomethacin (IND) loaded polymeric micelles based on PNIPAAm/EAB-PPPs were prepared by dialysis procedure. In vitro IND release kinetics was investigated in 0.1 M PBS (pH 7.4), while in vivo pharmacokinetics was performed in Sprague-Dawley rats. In vivo pharmacodynamic study was carried out based on two animal models, i.e. carrageenan-induced acute paw edema and complete Freund's adjuvant (CFA) induced ankle arthritis model. RESULTS: Drug loading capacity of micelles based on this type of amphiphilic copolymers was mainly determined by copolymer composition and the chemical structure of drug. In addition to the compatibility between drug and micellar core, hydrogen bonding interaction between drug and hydrophilic corona may significantly influence drug loading as well. In vitro drug release in PBS suggested that there was no significant difference in release rate between micelles based on copolymers with various EAB content. Compared with the rats administered with free IND aqueous solution, IND concentration in rats' plasma showed a prolonged maintenance in experimental group treated with IND-loaded polymeric micelles. In vivo pharmacodynamic study indicated that sustained therapeutic efficacy could be achieved through topical injection of the aqueous solution of IND-loaded micelles. Local delivery of IND can avoid the severe gastrointestinal stimulation, which was frequently associated with oral administration as evidenced by ulceration evaluation. CONCLUSIONS: The promising results of current preliminary study suggest that this type of amphiphilic copolymers could be used as injectable drug carriers for hydrophobic drugs.
Authors: Dong Wang; Scott C Miller; Monika Sima; Dennis Parker; Henry Buswell; K Craig Goodrich; Pavla Kopecková; Jindrich Kopecek Journal: Pharm Res Date: 2004-10 Impact factor: 4.200
Authors: Taylor E Kavanaugh; Thomas A Werfel; Hongsik Cho; Karen A Hasty; Craig L Duvall Journal: Drug Deliv Transl Res Date: 2016-04 Impact factor: 4.617
Authors: A Bernardi; A C C V Zilberstein; E Jäger; M M Campos; F B Morrone; J B Calixto; A R Pohlmann; S S Guterres; A M O Battastini Journal: Br J Pharmacol Date: 2009-05-06 Impact factor: 8.739
Authors: Nitin Joshi; Jing Yan; Seth Levy; Sachin Bhagchandani; Kai V Slaughter; Nicholas E Sherman; Julian Amirault; Yufeng Wang; Logan Riegel; Xueyin He; Tan Shi Rui; Michael Valic; Praveen K Vemula; Oscar R Miranda; Oren Levy; Ellen M Gravallese; Antonios O Aliprantis; Joerg Ermann; Jeffrey M Karp Journal: Nat Commun Date: 2018-04-03 Impact factor: 14.919
Authors: Hala M Helal; Wael M Samy; Elbadawy A Kamoun; Esmail M El-Fakharany; Doaa A Abdelmonsif; Rania G Aly; Sana M Mortada; Marwa A Sallam Journal: Int J Nanomedicine Date: 2021-07-14